Literature DB >> 7654688

Multiple-state equilibrium unfolding of guanidino kinases.

M Gross1, A Lustig, T Wallimann, R Furter.   

Abstract

The denaturant-induced equilibrium unfolding of octameric mitochondrial creatine kinase, dimeric cytosolic muscle-type creatine kinase, and monomeric arginine kinase was investigated. Stable unfolding intermediates for all three enzymes were manifested by a strongly biphasic red shift of intrinsic protein fluorescence upon increasing denaturant concentrations. In the intermediate state, all proteins were monomeric and enzymatically inactive, but still retained a globular shape. Native tertiary structure interactions were largely disrupted, while at least 50% of the secondary structures were conserved, as suggested by near- and far-UV circular dichroism, respectively. A significantly increased surface hydrophobicity of the intermediate conformation, compared to both the native and the fully unfolded states, was observed by the binding of the hydrophobic fluorescent dye ANS. The observed properties agree formally with the definition of the molten globule state, but can be alternatively explained by a sequential unfolding of individual domains, involving a transient exposure of domain interfaces. Very similar unfolding profiles for all three proteins suggest that the formation of stable unfolding intermediates is not a consequence of the specific oligomeric structures of the CKs but rather due to a common, probably two-domain architecture of the guanidino kinase protomers.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7654688     DOI: 10.1021/bi00033a005

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  12 in total

1.  Crystal structure of brain-type creatine kinase at 1.41 A resolution.

Authors:  M Eder; U Schlattner; A Becker; T Wallimann; W Kabsch; K Fritz-Wolf
Journal:  Protein Sci       Date:  1999-11       Impact factor: 6.725

2.  Reactivation and refolding of reassociated dimers of rabbit muscle creatine kinase.

Authors:  Y D Park; K Huang; H M Zhou
Journal:  J Protein Chem       Date:  2000-04

3.  Effect of Mg2+ during reactivation and refolding of guanidine hydrochloride-denatured creatine kinase.

Authors:  Y D Park; H M Zhou
Journal:  J Protein Chem       Date:  2000-04

4.  Conformational change in the C-terminal domain is responsible for the initiation of creatine kinase thermal aggregation.

Authors:  Hua-Wei He; Jun Zhang; Hai-Meng Zhou; Yong-Bin Yan
Journal:  Biophys J       Date:  2005-07-08       Impact factor: 4.033

5.  Unfolding and refolding of dimeric creatine kinase equilibrium and kinetic studies.

Authors:  Y X Fan; J M Zhou; H Kihara; C L Tsou
Journal:  Protein Sci       Date:  1998-12       Impact factor: 6.725

6.  Reconstitution of active octameric mitochondrial creatine kinase from two genetically engineered fragments.

Authors:  M Gross; M Wyss; E M Furter-Graves; T Wallimann; R Furter
Journal:  Protein Sci       Date:  1996-02       Impact factor: 6.725

7.  Protease digestion studies of an equilibrium intermediate in the unfolding of creatine kinase.

Authors:  T Webb; P J Jackson; G E Morris
Journal:  Biochem J       Date:  1997-01-01       Impact factor: 3.857

8.  Structural characterization of Escherichia coli sensor histidine kinase EnvZ: the periplasmic C-terminal core domain is critical for homodimerization.

Authors:  Ahmad Khorchid; Masayori Inouye; Mitsuhiko Ikura
Journal:  Biochem J       Date:  2005-01-01       Impact factor: 3.857

9.  Cardiac muscle ring finger-1 increases susceptibility to heart failure in vivo.

Authors:  Monte S Willis; Jonathan C Schisler; Luge Li; Jessica E Rodríguez; Eleanor G Hilliard; Peter C Charles; Cam Patterson
Journal:  Circ Res       Date:  2009-06-04       Impact factor: 17.367

10.  The carp muscle-specific sub-isoenzymes of creatine kinase form distinct dimers at different temperatures.

Authors:  Hsi-Wen Sun; Cheng-Wen Liu; Cho-Fat Hui; Jen-Leih Wu
Journal:  Biochem J       Date:  2002-12-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.